These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 21544242)

  • 1. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression.
    Liu LZ; Li C; Chen Q; Jing Y; Carpenter R; Jiang Y; Kung HF; Lai L; Jiang BH
    PLoS One; 2011 Apr; 6(4):e19139. PubMed ID: 21544242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.
    Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G
    Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
    Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
    PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
    Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization.
    Yang XM; Wang YS; Zhang J; Li Y; Xu JF; Zhu J; Zhao W; Chu DK; Wiedemann P
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1873-9. PubMed ID: 19098317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
    J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells.
    Jing Y; Liu LZ; Jiang Y; Zhu Y; Guo NL; Barnett J; Rojanasakul Y; Agani F; Jiang BH
    Toxicol Sci; 2012 Jan; 125(1):10-9. PubMed ID: 21984483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH oxidase 4 mediates insulin-stimulated HIF-1α and VEGF expression, and angiogenesis in vitro.
    Meng D; Mei A; Liu J; Kang X; Shi X; Qian R; Chen S
    PLoS One; 2012; 7(10):e48393. PubMed ID: 23144758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway.
    Park JJ; Hwang SJ; Park JH; Lee HJ
    Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells.
    Jeong JH; Jeong YJ; Cho HJ; Shin JM; Kang JH; Park KK; Park YY; Chung IK; Chang HW; Magae J
    J Cell Biochem; 2012 Apr; 113(4):1302-13. PubMed ID: 22109717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis.
    Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K
    Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog.
    Seok JK; Lee SH; Kim MJ; Lee YM
    Nucleic Acids Res; 2014 Jul; 42(12):8062-72. PubMed ID: 24914051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1α pathway.
    Liu LZ; Jing Y; Jiang LL; Jiang XE; Jiang Y; Rojanasakul Y; Jiang BH
    Biochem Biophys Res Commun; 2011 Sep; 413(2):299-305. PubMed ID: 21893035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
    Dewangan J; Kaushik S; Rath SK; Balapure AK
    Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
    Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
    Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.
    Tang X; Zhang Q; Shi S; Yen Y; Li X; Zhang Y; Zhou K; Le AD
    Int J Cancer; 2010 Jan; 126(1):90-103. PubMed ID: 19569175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.